Stockholders' Equity	9 Months Ended
Sep. 30, 2020
Equity [Abstract]
Stockholders' Equity	10. Stockholders’ Equity Preferred Stock The Company currently has 50,000,000 shares of preferred stock authorized. Series A Convertible Preferred Stock During the quarter and nine months ended September 30, 2020, the Company did not issue dividends of Series A convertible preferred stock to the holders of the Series A convertible preferred stock. As of September 30, 2020, dividends in arrears were $20. Common Stock As of September 30, 2020, the Company has reserved 14,154,410 shares of common stock for future issuances related to employee stock compensation plans. On August 5, 2019, the Company’s Board of Directors authorized a stock repurchase program under which the Company may repurchase up to $25,000 of the Company’s outstanding shares of common stock through open market transactions and privately negotiated transactions, until August 5, 2020. In addition, open market repurchases of common stock may be made pursuant to applicable securities laws and regulations, including Rule 10b-18, as well as Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. During the nine months ended September 30, 2020, the Company repurchased 836,904 shares at an average share price of $2.98. As of September 30, 2020, authorization for approximately $13,112 of the Company’s common stock remained available for future purchases under the repurchase program. In mid-March 2020, the Company suspended further purchases given the economic uncertainty resulting from the COVID-19 pandemic.

Stockholders' Equity

9 Months Ended

Sep. 30, 2020

10. Stockholders’ Equity

Preferred Stock

The Company currently has 50,000,000 shares of preferred stock authorized.

Series A Convertible Preferred Stock

During the quarter and nine months ended September 30, 2020, the Company did not issue dividends of Series A convertible preferred stock to the holders of the Series A convertible preferred stock. As of September 30, 2020, dividends in arrears were $20.

Common Stock

As of September 30, 2020, the Company has reserved 14,154,410 shares of common stock for future issuances related to employee stock compensation plans.

On August 5, 2019, the Company’s Board of Directors authorized a stock repurchase program under which the Company may repurchase up to $25,000 of the Company’s outstanding shares of common stock through open market transactions and privately negotiated transactions, until August 5, 2020. In addition, open market repurchases of common stock may be made pursuant to applicable securities laws and regulations, including Rule 10b-18, as well as Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. During the nine months ended September 30, 2020, the Company repurchased 836,904 shares at an average share price of $2.98. As of September 30, 2020, authorization for approximately $13,112 of the Company’s common stock remained available for future purchases under the repurchase program. In mid-March 2020, the Company suspended further purchases given the economic uncertainty resulting from the COVID-19 pandemic.